Saliva SARS-Cov-2(2019-nCoV)Antigen Combo Assay （Nanocarbon Assay）
The One Step SARS-CoV-2 N/ S antigen Test Device is a lateral flow, one-step immunoassay for the qualitative detection of novel coronavirus N/ S antigen in Saliva sample. This product is used to obtain a visual, qualitative results and is intended for
professional use.
This assay provides only a preliminary analytical test result. A more specific alternate method must be used in order to obtain a confirmed analytical result. Virus nucleic acid test is the preferred confirmatory method.
The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected
people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose,
sore throat, myalgia and diarrhea are found in a few cases.
中文版
English
